Switching between reference adalimumab and biosimilars in chronic immune‐mediated inflammatory diseases: A systematic literature review

…, M Samartín‐Ucha, M GayosoRey… - British Journal of …, 2022 - Wiley Online Library
Aims Adalimumab is a biological therapy used to treat different chronic inflammatory diseases.
At present, there is an increasing number of adalimumab biosimilars. To assume the …

Factors associated with patient satisfaction in an outpatient hospital pharmacy

…, P Iglesias-Neiro, M Gayoso-Rey… - European journal of …, 2018 - ejhp.bmj.com
Objective To analyse the factors leading to greater satisfaction among patients attending the
outpatient hospital pharmacy (OPh). Methods A cross-sectional study was conducted of …

Effectiveness, safety, and adherence to treatment of proprotein convertase subtilisin/Kexin Type 9 inhibitors in real practice

M Gayoso-Rey, O Díaz-Trastoy, EY Romero-Ventosa… - Clinical Therapeutics, 2021 - Elsevier
Purpose To evaluate the effectiveness, adverse reactions, and adherence to treatment of
hypolipidemic inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9is) in a context …

[HTML][HTML] Real-world evidence for Treat-and-Extend regimen of ranibizumab therapy for macular oedema secondary to branch retinal vein occlusion

…, A Campo-Gesto, A López-López, M Gayoso-Rey - Pharmaceuticals, 2022 - mdpi.com
The aim of this study was to evaluate the efficacy of a treat-and-extend (T&E) regimen of
ranibizumab as the first-choice treatment in macular oedema (MO) secondary to branch retinal …

[HTML][HTML] Metodología Lean: diseño y evaluación de un modelo estandarizado de almacenaje de medicación

M Gayoso-Rey, NML de Castro… - Farmacia …, 2020 - revistafarmaciahospitalaria.sefh.es
Objetivo: El objetivo del estudio es evaluar los resultados de la aplicación de la metodología
Lean en el diseño de un modelo estandarizado de almacenaje de medicación en las …

Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors

J Seijas-Amigo, M Gayoso-Rey… - Clínica e Investigación …, 2022 - Elsevier
Objectives MEMOGAL study (NCT04319081) is aimed at evaluating changes in cognitive
function in patients treated with PCSK9 inhibitors (PCSK9i). This is the first analysis: (1) …

[HTML][HTML] Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

…, P Suarez-Artime, M Gayoso-Rey… - American Journal of …, 2023 - Springer
Introduction The cognitive safety of monoclonal antibody proprotein convertase subtilisin/kexin
type 9 inhibitors (PCSK9i) has been established in clinical trials, but not yet in real-world …

Impacto de la pandemia por COVID-19 en el control lipídico de pacientes que inician inhibidores de la PCSK9

J Seijas-Amigo, M Gayoso-Rey… - Clínica e investigación …, 2022 - Elsevier
Objetivos El estudio MEMOGAL (NCT04319081) está dirigido a evaluar cambios en la función
cognitiva en pacientes tratados con inhibidores de la PCSK9 (iPCSK9). Se realiza primer …

[HTML][HTML] Regorafenib and trifluridine/tipiracil in real clinical practice

…, EY Romero-Ventosa, M Gayoso-Rey… - Journal of Cancer …, 2022 - journals.lww.com
Background: Colorectal cancer is the ninth leading cause of death in Spain. The latest
therapeutic developments in the advanced stages of this disease are the oral drugs trifluridine/…

[HTML][HTML] LEAN methodology: design and assessment of a standardized medication storage model

M Gayoso-Rey, NML de Castro… - Farmacia …, 2021 - Elsevier
Objective The objective of this study was to assess the results of applying Lean Methodology
in the design of a standardized medication storage model in hospitalization departments. …